TIDU, Federico, Marco DE ZUANI, Shyam Sushama JOSE, Kamila BENDICKOVA, Lukáš KUBALA, Frank CARUSO, Francesca CAVALIERI, Giancarlo FORTE and Jan FRIČ. NFAT signaling in human mesenchymal stromal cells affects extracellular matrix remodeling and antifungal immune responses. iSCIENCE. CAMBRIDGE: CELL PRESS, 2021, vol. 24, No 6, p. 1-24. ISSN 2589-0042. Available from: https://dx.doi.org/10.1016/j.isci.2021.102683.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name NFAT signaling in human mesenchymal stromal cells affects extracellular matrix remodeling and antifungal immune responses
Authors TIDU, Federico (380 Italy, belonging to the institution), Marco DE ZUANI, Shyam Sushama JOSE (203 Czech Republic), Kamila BENDICKOVA (203 Czech Republic), Lukáš KUBALA (203 Czech Republic), Frank CARUSO, Francesca CAVALIERI, Giancarlo FORTE (380 Italy) and Jan FRIČ (203 Czech Republic, guarantor).
Edition iSCIENCE, CAMBRIDGE, CELL PRESS, 2021, 2589-0042.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10700 1.7 Other natural sciences
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 6.107
RIV identification code RIV/00216224:14110/21:00122134
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.isci.2021.102683
UT WoS 000667301700118
Keywords in English NFAT signaling; human mesenchymal stromal cells
Tags 14110513, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 25/3/2022 09:14.
Abstract
Mesenchymal stromal cells (MSCs) combined with calcineurin-nuclear factor of activated T cell (CN-NFAT) inhibitors are being tested as a treatment for graft-versus-host disease (GvHD). The immunosuppressive properties of MSCs seem beneficial; however, their response during fungal infection, which is an important cause of mortality in patients with GvHD, is unknown. We report that MSCs phagocytose the fungal component zymosan, resulting in phosphorylation of spleen tyrosine kinase (Syk), increase in cytosolic calcium levels, and ultimately, increase in NFAT1 nuclear translocation. RNA sequencing analysis of zymosan-treated MSCs showed that CN-NFAT inhibition affects extracellular matrix (ECM) genes but not cytokine expression that is under the control of the NF-kappa B pathway. When coculturing MSCs or decellularized MSC-ECM with human peripheral blood mononuclear cells (PBMCs), selective NFAT inhibition in MSCs decreased cytokine expression by PBMCs. These findings reveal a dual mechanism underlying the MSC response to zymosan: while NF-kappa B directly controls inflammatory cytokine expression, NFAT impacts immune-cell functions by regulating ECM remodeling.
Links
LM2015091, research and development projectName: Národní centrum lékařské genomiky (Acronym: NCLG)
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 17/7/2024 16:36